Abstract
In this paper we describe a molecular beacon format assay in which encoded nanowire particles are used to achieve multiplexing. We demonstrate this principle with the detection of five viral pathogens; Hepatitis A virus, Hepatitis C virus, West Nile Virus, Human Immune Deficiency virus and Severe Acute Respiratory Syndrome virus. Oligonucleotides are designed complementary to a target sequence of interest containing a 3′ universal fluorescence dye. A 5′ thiol causes the oligonucleotides to self-assemble onto the metal nanowire. The single-stranded oligonucleotide contains a self-complementary hairpin stem sequence of 10 bases that forces the 3′ fluorophore to come into contact with the metallic nanowire surface, thereby quenching the fluorescence. Upon addition of target DNA, there is hybridization with the complementary oligonucleotides. The resulting DNA hybrid is rigid, unfolds the hairpin structure, and causes the fluorophore to be moved away from the surface such that it is no longer quenched. By using differently encoded nanowires, each conjugated with a different oligonucleotide sequence, multiplexed DNA assays are possible using a single fluorophore, from a multiplexed RT-PCR reaction.
Original language | English |
---|---|
Pages (from-to) | 327-335 |
Number of pages | 9 |
Journal | Nanobiotechnology |
Volume | 1 |
Issue number | 4 |
DOIs | |
State | Published - 2005 |
Externally published | Yes |
Bibliographical note
Funding Information:Authors thank Gabriela Chakarova and Frances Wong for nanowire synthesis. Work at Nanoplex Technologies Inc. was funded by the National Science Foundation, through an SBIR Phase 1 grant (0418748), and by the National Institute of Standards and Technology (Grant 70NANB1H3028). Work at Penn State University was funded by the National Institutes of Health (RO1 EB00268). CDK also acknowledges support from a Beckman Foundation Young Investigator Award and a Sloan Fellowship.
Funding
Authors thank Gabriela Chakarova and Frances Wong for nanowire synthesis. Work at Nanoplex Technologies Inc. was funded by the National Science Foundation, through an SBIR Phase 1 grant (0418748), and by the National Institute of Standards and Technology (Grant 70NANB1H3028). Work at Penn State University was funded by the National Institutes of Health (RO1 EB00268). CDK also acknowledges support from a Beckman Foundation Young Investigator Award and a Sloan Fellowship.
Funders | Funder number |
---|---|
Beckman Foundation | |
National Science Foundation | |
National Institutes of Health | RO1 EB00268 |
National Institute of Standards and Technology | 70NANB1H3028 |
Small Business Innovation Research | 0418748 |
Keywords
- Encoded
- Molecular beacon
- Multiplex
- Nanotechnology
- Nanowire
- Pathogen
- RNA detection